INSM1, a Novel Biomarker for Detection of Neuroendocrine Neoplasms: Cytopathologists’ View

Background: Insulinoma-associated protein 1 (INSM1) has been considered as a novel immunostain for neuroendocrine tumors (NETs) and is hypothesized to be more reliable than first-generation NET biomarkers, such as CGA (chromogranin A), SYP (synaptophysin) and CD56 (neural cell adhesion molecule). In...

Full description

Bibliographic Details
Main Authors: Zahra Maleki, Akash Nadella, Mohnish Nadella, Gopi Patel, Shivni Patel, Ivana Kholová
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/11/12/2172
_version_ 1797505550135590912
author Zahra Maleki
Akash Nadella
Mohnish Nadella
Gopi Patel
Shivni Patel
Ivana Kholová
author_facet Zahra Maleki
Akash Nadella
Mohnish Nadella
Gopi Patel
Shivni Patel
Ivana Kholová
author_sort Zahra Maleki
collection DOAJ
description Background: Insulinoma-associated protein 1 (INSM1) has been considered as a novel immunostain for neuroendocrine tumors (NETs) and is hypothesized to be more reliable than first-generation NET biomarkers, such as CGA (chromogranin A), SYP (synaptophysin) and CD56 (neural cell adhesion molecule). In this review, we summarize existing literature on INSM1′s reliability as an immunostain for detection of various NETs, its results in comparison to first-generation NET biomarkers, and its expression in both non-NETs and benign tissues/cells on cytology specimens (cell blocks/smears).
first_indexed 2024-03-10T04:20:11Z
format Article
id doaj.art-a81e37372d974a4ea392ac34c05e6496
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-10T04:20:11Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-a81e37372d974a4ea392ac34c05e64962023-11-23T07:52:25ZengMDPI AGDiagnostics2075-44182021-11-011112217210.3390/diagnostics11122172INSM1, a Novel Biomarker for Detection of Neuroendocrine Neoplasms: Cytopathologists’ ViewZahra Maleki0Akash Nadella1Mohnish Nadella2Gopi Patel3Shivni Patel4Ivana Kholová5Division of Cytopathology, Department of Pathology, The Johns Hopkins Hospital, The Johns Hopkins Medical Institution, Baltimore, MD 21218, USADepartment of Pathology, Johns Hopkins University, Baltimore, MD 21218, USADepartment of Pathology, Johns Hopkins University, Baltimore, MD 21218, USADepartment of Pathology, Johns Hopkins University, Baltimore, MD 21218, USADepartment of Pathology, Johns Hopkins University, Baltimore, MD 21218, USADepartment of Pathology, Fimlab Laboratories, Tampere, Faculty of Medicine and Health Technology, Tampere University, 33100 Tampere, FinlandBackground: Insulinoma-associated protein 1 (INSM1) has been considered as a novel immunostain for neuroendocrine tumors (NETs) and is hypothesized to be more reliable than first-generation NET biomarkers, such as CGA (chromogranin A), SYP (synaptophysin) and CD56 (neural cell adhesion molecule). In this review, we summarize existing literature on INSM1′s reliability as an immunostain for detection of various NETs, its results in comparison to first-generation NET biomarkers, and its expression in both non-NETs and benign tissues/cells on cytology specimens (cell blocks/smears).https://www.mdpi.com/2075-4418/11/12/2172cytologyneuroendocrine tumorINSM-1 immunostainingmedullary thyroid carcinomapancreatic neuroendocrine tumorpulmonary neuroendocrine neoplasms
spellingShingle Zahra Maleki
Akash Nadella
Mohnish Nadella
Gopi Patel
Shivni Patel
Ivana Kholová
INSM1, a Novel Biomarker for Detection of Neuroendocrine Neoplasms: Cytopathologists’ View
Diagnostics
cytology
neuroendocrine tumor
INSM-1 immunostaining
medullary thyroid carcinoma
pancreatic neuroendocrine tumor
pulmonary neuroendocrine neoplasms
title INSM1, a Novel Biomarker for Detection of Neuroendocrine Neoplasms: Cytopathologists’ View
title_full INSM1, a Novel Biomarker for Detection of Neuroendocrine Neoplasms: Cytopathologists’ View
title_fullStr INSM1, a Novel Biomarker for Detection of Neuroendocrine Neoplasms: Cytopathologists’ View
title_full_unstemmed INSM1, a Novel Biomarker for Detection of Neuroendocrine Neoplasms: Cytopathologists’ View
title_short INSM1, a Novel Biomarker for Detection of Neuroendocrine Neoplasms: Cytopathologists’ View
title_sort insm1 a novel biomarker for detection of neuroendocrine neoplasms cytopathologists view
topic cytology
neuroendocrine tumor
INSM-1 immunostaining
medullary thyroid carcinoma
pancreatic neuroendocrine tumor
pulmonary neuroendocrine neoplasms
url https://www.mdpi.com/2075-4418/11/12/2172
work_keys_str_mv AT zahramaleki insm1anovelbiomarkerfordetectionofneuroendocrineneoplasmscytopathologistsview
AT akashnadella insm1anovelbiomarkerfordetectionofneuroendocrineneoplasmscytopathologistsview
AT mohnishnadella insm1anovelbiomarkerfordetectionofneuroendocrineneoplasmscytopathologistsview
AT gopipatel insm1anovelbiomarkerfordetectionofneuroendocrineneoplasmscytopathologistsview
AT shivnipatel insm1anovelbiomarkerfordetectionofneuroendocrineneoplasmscytopathologistsview
AT ivanakholova insm1anovelbiomarkerfordetectionofneuroendocrineneoplasmscytopathologistsview